Internal Medicine, Cardiovascular Disease · Chestnut Hill, MA
NPI
1346349669
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
200 Boylston St Ste A309
Chestnut Hill, MA, 02467
Phone (617) 277-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$569K
283,463 services
Medicare patients, 2024
730
Average age 75
Drug cost, 2024
$528K
3,195 prescriptions
Company payments, 2025
$1,737
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Evan Appelbaum was code J3145 (injection, testosterone undecanoate, 1 mg), 179,250 times for 63 patients. In total Evan Appelbaum billed 283,463 services in 42 codes, and Medicare paid $569K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3145 Injection, testosterone undecanoate, 1 mg | Office | 179,250 | 63 | $1.48 | $265K |
| J1071 Injection, testosterone cypionate, 1 mg | Office | 98,212 | 45 | $0.02 | $1,737 |
| 99214 Office E&M - Established | Office | 901 | 485 | $100.94 | $91K |
| 96372 Injection Administration | Office | 634 | 93 | $11.90 | $7,546 |
| J3490 Unclassified drugs | Office | 456 | 40 | $69.93 | $32K |
| 84403 Clinical Chemistry | Office | 409 | 254 | $25.29 | $10K |
| 99213 Office E&M - Established | Office | 389 | 232 | $74.34 | $29K |
| 82670 Clinical Chemistry | Office | 385 | 255 | $27.38 | $11K |
| 83002 Clinical Chemistry | Office | 373 | 252 | $18.15 | $6,770 |
| 83001 Clinical Chemistry | Office | 368 | 250 | $18.21 | $6,701 |
| 84270 Clinical Chemistry | Office | 359 | 245 | $21.30 | $7,647 |
| 84153 Clinical Chemistry | Office | 355 | 250 | $18.02 | $6,397 |
| 93000 Electrocardiogram | Office | 301 | 241 | $11.49 | $3,458 |
| 93306 Echocardiography (TTE/TEE) | Office | 255 | 131 | $94.02 | $24K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 109 | 63 | $99.99 | $11K |
By year: 2022 $769K for 365,609 services; 2023 $682K for 338,946 services; 2024 $569K for 283,463 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84403 Clinical Chemistry | 409 | 254 | $25.29 | $10K |
| 82670 Clinical Chemistry | 385 | 255 | $27.38 | $11K |
| 83002 Clinical Chemistry | 373 | 252 | $18.15 | $6,770 |
| 83001 Clinical Chemistry | 368 | 250 | $18.21 | $6,701 |
| 84270 Clinical Chemistry | 359 | 245 | $21.30 | $7,647 |
| 84153 Clinical Chemistry | 355 | 250 | $18.02 | $6,397 |
| 84443 Clinical Chemistry | 39 | 37 | $16.46 | $642 |
| 84439 Clinical Chemistry | 33 | 31 | $8.84 | $292 |
| 84146 Clinical Chemistry | 31 | 31 | $18.99 | $589 |
| 84144 Clinical Chemistry | 27 | 27 | $20.44 | $552 |
Medicare prescription drug claims, 2024
In 2024, the drug Evan Appelbaum prescribed most often to Medicare patients was Testosterone Cypionate, with 865 prescriptions and refills. In total Evan Appelbaum wrote 3,195 Medicare prescriptions that cost $528K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Testosterone Cypionate Generic | 865 | 896 | 173 | $33K |
| Rosuvastatin Calcium Generic | 184 | 505 | 54 | $6,987 |
| Atorvastatin Calcium Generic | 154 | 426 | 43 | $1,943 |
| Xarelto Rivaroxaban | 121 | 237 | 22 | $127K |
| Atenolol Generic | 118 | 328 | 32 | $930 |
| Metoprolol Succinate Generic | 109 | 287 | 27 | $2,661 |
| Xyosted Testosterone Enanthate | 105 | 105 | 13 | $63K |
| Eliquis Apixaban | 104 | 209 | 21 | $116K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 102 | 263 | 31 | $2,701 |
| Tamsulosin Hcl Generic | 102 | 286 | 42 | $2,434 |
| Losartan Potassium Generic | 88 | 247 | 25 | $1,165 |
| Testosterone Generic | 81 | 85 | 22 | $14K |
| Cabergoline Generic | 79 | 140 | 23 | $5,574 |
| Amlodipine Besylate Generic | 58 | 166 | 18 | $458 |
| Hydrochlorothiazide Generic | 50 | 121 | 13 | $99.81 |
Brand drugs: - claims; generic drugs: 2,678 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Evan Appelbaum $1,737 ($1,737 in general payments such as food, travel and fees) from 20 companies. The largest payer was Antares Pharma, Inc. with $380.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.